Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, California; Department of Ophthalmology, Federal University of São Paulo, Brazil.
Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, California.
Ophthalmology. 2014 Feb;121(2):498-507. doi: 10.1016/j.ophtha.2013.09.016. Epub 2013 Nov 26.
To evaluate the ability of longitudinal frequency doubling technology (FDT) to predict the development of glaucomatous visual field loss on standard automated perimetry (SAP) in glaucoma suspects.
Prospective, observational cohort study.
The study included 587 eyes of 367 patients with suspected glaucoma at baseline selected from the Diagnostic Innovations in Glaucoma Study (DIGS) and the African Descent and Glaucoma Evaluation Study (ADAGES). These eyes had an average of 6.7 ± 1.9 FDT tests during a mean follow-up time of 73.1 ± 28.0 months.
Glaucoma suspects had intraocular pressure (IOP) >21 mmHg or an optic disc appearance suspicious of glaucoma. All patients had normal or nonrepeatable abnormal SAP at baseline. Humphrey Matrix FDT (Carl Zeiss Meditec, Inc, Dublin, CA) testing was performed within 6 months of SAP testing. The study end point was the development of 3 consecutive abnormal SAP test results. Joint longitudinal survival models were used to evaluate the ability of rates of FDT pattern standard deviation (PSD) change to predict the development of visual field loss on SAP, adjusting for confounding variables (baseline age, mean IOP, corneal thickness, and follow-up measurements of SAP PSD).
The R(2) index was used to evaluate and compare the predictive abilities of the model containing longitudinal FDT PSD data with the model containing only baseline data.
Sixty-three of 587 eyes (11%) developed SAP visual field loss during follow-up. The mean rate of FDT PSD change in eyes that developed SAP visual field loss was 0.07 dB/year versus 0.02 dB/year in those that did not (P < 0.001). Baseline FDT PSD and slopes of FDT PSD change were significantly predictive of progression, with hazard ratios of 1.11 per 0.1 dB higher (95% confidence interval [CI], 1.04-1.18; P = 0.002) and 4.40 per 0.1 dB/year faster (95% CI, 1.08-17.96; P = 0.04), respectively. The longitudinal model performed significantly better than the baseline model with an R(2) of 82% (95% CI, 74-89) versus 11% (95% CI, 2-24), respectively.
Rates of FDT PSD change were highly predictive of the development of SAP visual field loss in glaucoma suspects. This finding suggests that longitudinal FDT evaluation may be useful for risk stratification of patients with suspected glaucoma.
评估纵向频域倍增技术(FDT)在预测疑似青光眼患者标准自动视野计(SAP)视野损失发展方面的能力。
前瞻性观察队列研究。
本研究纳入了基线时来自诊断性青光眼创新研究(DIGS)和非裔美国人青光眼评估研究(ADAGES)的 367 名疑似青光眼患者的 587 只眼。这些眼睛在平均 73.1±28.0 个月的随访期间平均接受了 6.7±1.9 次 FDT 检查。
疑似青光眼患者的眼压(IOP)>21mmHg 或视盘外观疑似青光眼。所有患者在基线时 SAP 检查均正常或不可重复异常。在 SAP 检查后 6 个月内进行 Humphrey Matrix FDT(Carl Zeiss Meditec,Inc,Dublin,CA)检查。研究终点为连续 3 次 SAP 检查结果异常。使用联合纵向生存模型评估 FDT 模式标准偏差(PSD)变化率预测 SAP 视野损失发展的能力,同时调整混杂变量(基线年龄、平均 IOP、角膜厚度和 SAP PSD 的随访测量值)。
R²指数用于评估和比较包含纵向 FDT PSD 数据的模型与仅包含基线数据的模型的预测能力。
587 只眼中有 63 只(11%)在随访期间发生了 SAP 视野损失。在发生 SAP 视野损失的眼中,FDT PSD 变化的平均速率为 0.07dB/年,而未发生 SAP 视野损失的眼中为 0.02dB/年(P<0.001)。基线 FDT PSD 和 FDT PSD 变化斜率均对进展具有显著预测性,风险比分别为每增加 0.1dB 增加 1.11(95%置信区间[CI]:1.04-1.18;P=0.002)和每增加 0.1dB/年增加 4.40(95%CI:1.08-17.96;P=0.04)。纵向模型的 R²为 82%(95%CI:74-89),明显优于基线模型的 11%(95%CI:2-24)。
FDT PSD 变化率对疑似青光眼患者 SAP 视野损失的发展具有高度预测性。这一发现表明,纵向 FDT 评估可能有助于疑似青光眼患者的风险分层。